ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice
January 29, 2022Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment of patients... -
FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion
January 28, 2022Dizal Pharmaceutical Co., Ltd. (SHEX:688192) ("Dizal"), today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation to DZD9008 (Sunvozertinib) for the treatment... -
AstraZeneca, Chinese FIIF establish joint venture Dizal Pharmaceutical in China
November 30, 2017Collaboration aims to accelerate local development of innovative medicines for patients in China and builds on AstraZeneca’s strong presence in the country
Pharma Sources Insight January 2025
